000 01452 a2200409 4500
005 20250515105817.0
264 0 _c20080408
008 200804s 0 0 eng d
022 _a0914-7187
024 7 _a10.1007/s12149-007-0080-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuan, Xiao-Yi
245 0 0 _aTechnetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
_h[electronic resource]
260 _bAnnals of nuclear medicine
_cJan 2008
300 _a49-55 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultidrug Resistance-Associated Proteins
_xblood
650 0 4 _aNeoplasm Proteins
_xblood
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aTechnetium Tc 99m Sestamibi
700 1 _aWang, Jian-Sheng
700 1 _aLiu, Min
700 1 _aGuo, You-Min
773 0 _tAnnals of nuclear medicine
_gvol. 22
_gno. 1
_gp. 49-55
856 4 0 _uhttps://doi.org/10.1007/s12149-007-0080-5
_zAvailable from publisher's website
999 _c17756768
_d17756768